Sorafenib N Oxide
ISO
583840-03-3
Pondicherry
10 mg
2024-12-31
Drug Impurity
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceA niacinamide and phenylurea derivative that inhibits multiple intracellular and cell surface kinases thought to be involved in ANGIOGENESIS, including RAF KINASES and VEGF RECEPTORS. It is used in the treatment of advanced RENAL CELL CARCINOMA and HEPATOCELLULAR CARCINOMA, and for treatment of THYROID CARCINOMA refractory to radioactive iodine therapy.CertificatesBasic Info
-
Product Name:
Sorafenib N-Oxide
Other Name:4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-1-oxidopyridin-1-ium-2-carboxamide;
CAS No.:583840-03-3
Molecular Formula:C21H13ClD3F3N4O4
InChIKeys:BQAZCCVUZDIZDC-UHFFFAOYSA-N
Molecular Weight:483.84300
Exact Mass:480.0812172
UNII:5XYK65KIGD
DSSTox ID:DTXSID60431376
Categories:
Characteristics-
PSA:
104.92000
XLogP3:6.12010
Density:1.455g/cm3
Melting Point:220-222ºC
Boiling Point:591.655ºC at 760 mmHg
Flash Point:311.622ºC
Refractive Index:1.601
Storage Conditions:-20ºC Freezer
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Drug Impurity
-
Location:
No 28, 3rd Cross street, Natesan Nagar( West) Pondicherry, India - 605005
-
Payment Terms:
100% TT in advance
-
Average lead Time:
50 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2012
Company Certificates-
Incorportation
-
ISO 9001:2015
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product